Marc van Gelder re-appointed Chief Executive Officer at Mediq
The Supervisory Committee of Mediq, international supplier of medical devices and pharmaceuticals, have re-appointed Marc van Gelder Chief Executive Officer (CEO) as of 1 January 2013.
The General Meeting of Shareholders of Mediq was informed at the annual shareholders meeting on 11 April 2012. Van Gelder is appointed for a period of 4 years. Van Gelder became a member of the Board of Management of Mediq as of 1 January 2005 and was appointed Chief Executive Officer per 1 December 2005. Before joining Mediq, he held positions at McKinsey & Company and Royal Ahold.